Proton magnetic resonance spectroscopy: The new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy?

Digestive Diseases

Volumn 14, Issue , 1996, Pages 30-39

  Ross, Brian D ^a   Danielsen, Else R ^a   Blüml, Stefan ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Encephalopathy; Glutamine; Liver disease; Magnetic resonance spectroscopy; Myoinositol; NMR spectroscopy; Subclinical hepatic encephalopathy; Transjugular intrahepatic portasystemic shunt; Transplantation

Indexed keywords

CHOLINE; DIAGNOSTIC AGENT; GLUTAMINE; HYDROGEN; INOSITOL; PROTON;

ANIMAL; ASTROCYTE; BRAIN; COGNITIVE DEFECT; DISEASE MODEL; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PORTOSYSTEMIC ANASTOMOSIS; REVIEW;

ANIMALS; ASTROCYTES; BRAIN; CHOLINE; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; HYDROGEN; INOSITOL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROTONS;

EID: 0009743529     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171581     Document Type: Article

References (23)

1. Ross BD, Kreis R, Ernst T: Clinical tools for the 90s: Magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992; 14:128-140.
2. Krais R, Farrow NA, Ross BD: Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 1990:336: 635-636.
3. Kreis R, Farrow NA, Ross BD: Localized 'H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116.
4. Kreis R, Ross BD, Farrow NA, Ackerman Z: Metabolic disorders of the brain in chronic hepatic encephalopathy detected with 'H MRS. Radiology 1992:182:19-27.
5. Krais R, Ross BD: Cerebral metabolic disturbances in patients with subacute and chronic diabetes rnelli-tus by proton magnetic resonance spectroscopy. Radiology 1992:184: 123-130.
6. Kreis R, Ernst T, Ross BD: Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Rcson 1993;102:9-19.
7. Ernst T, Kreis R, Ross BD: Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Rcson 1993;102:1-8.
8. Gitlin N, Lewis DC, Hinklcy L: The diagnosis and prevalence of subclin-ical hepatic encephalopathy in apparently healthy, ambulant, nonshunted patients with cirrhosis. J Hepatol 1986;3:75-82.
9. RSNA: Abstracted from several presentations at the 78th Annual Meeting of the Radiological Society of North America, Chicago, Nov 29-Dec 4 1992.
10. Michaelis T, Moats RA, Lien Y-HH, Ross BD: Depiction of cerebral inositols in rat and human: A HPLC and 'H MRS study of an animal model. Proc 12th Society of Magnetic Resonance in Medicine, New York 1993, vol 1, p 437.
11. Moats RA, Lien Y-HH, Filippi D, Ross BD: Decrease in cerebral inositols in rats and humans. Biochem J 1993;295:15-18.
12. Huda A, Thomas A, Bugbce M, Ke Y, Oshiro T, Strouse T, Guze B: Proton MR spectroscopy of hepatic encephalopathy. Proc 3rd Society of Magnetic Resonance, Nice 1995, vol 3, p 60.
13. Lee JH, Choi CG, Lee YS, Suh DC, Lim T-H: Localized proton MRS of the basal ganglia in liver cirrhosis and hepatic encephalopathy. Proc 3rd Society of Magnetic Resonance. Nice 1995, vol 3, p 1837.
14. Michaelis T, Mcrboldt K-D, Ha-nickc W, Gyngell ML, Bruhn H, Frahm J: On the identification of cerebral metabolites in localized 'H NMR spectra of human brain in vivo. NMR Biomed 1991:4:90-98.
15. Ziyeh S, Elverfcldt D, Thiel T, Pfarr S, Hennig J: Proton MRS in valproate-induced hyperammonemia with encephalopathy. Proc 3rd Society of Magnetic Resonance, Nice 1995. vol 3, p 1836.
16. Danielsen ER, Ernst T, Gcissler A, Villamil F, Michaelis T, Ross BD: Is hepatic encephalopathy a disturbance of cerebral osmolytes? Proc 3rd Society of Magnetic Resonance. Nice 1995. vol 3. p 1839.
17. Vogels BAPM, Karlsen OT, Bovee WMMJ, Chamuleau RAFM: Ornithine treatment of hyperammonemia-induced encephalopathy: The efficacy and mechanism studied by in vivo brain proton MRS. Proc 3rd Society of Magnetic Resonance. Nice 1995, vol 3, p 1759.
18. Ross BD, Danielsen ER, Mandigo JC, Potential for cost benefit in clinical trials through use of 'H MRS. Proc 3rd Society of Magnetic Resonance, Nice 1995, vol 1, p 208.
19. Jacobson S, Shonk T, Dragucsku J, Moats RA, Ernst T, Ross BD: Proton MRS in Hepatic Encephalopathy. 146th Meeting of the American Psychiatry Association, San Francisco, May 22-27, 1993.
20. Farrow NA, Korula J, Kreis R, Ernst T, Villamil F, Shonk T, Ross BD: Does TIPS induce hepatic encephalopathy? 78th Meeting of the Radiological Society of North America, Chicago, Nov 29-Dec 4. 1992.
21. Shonk T, Moats R, Lee JH, Korula J, Ernst T, Kreis R, Draguesku J, Ross BD: Increased incidence of sub-clinical hepatic encephalopathy associated with TIPS procedure. Gastroenterology 1993;104:A449.
22. Villamil F, Ernst T, Ross BD, Kreis R, Geissler A, Moats R, Shonk T, Jacobson S: Reversal of hepatic encephalopathy after liver transplantation: A proton MRS study. American Association for the Study of Liver Diseases/American Gastroenterological Association, Boston. May 16-19, 1993.
23. Geissler A, Farrow NA, Villamil F, Makowka L, Ernst T, Kreis R, Ross BD: Is hepatic encephalopathy reversed by liver transplantation? Proc 11th Society of Magnetic Resonance in Medicine. Berlin 1993. vol 1, p 494.